Send feedback

NIPBL p.Ser161=

c.483C>T · rs536895037 · VCV1743476

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 4 submitters
gnomAD v4.1
Rare
rare (popmax 0.193%, sas)
Conditions
1
Cornelia de Lange syndrome 1

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.7GERP 2.6, phastCons 1
Overall
CADD14.7PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.193% South Asian · 176/91,088 alleles
Filtering AF 0.17% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.161%
Overall 0.0126% 204/1,614,100 alleles · rare exomes 186/1,461,826 · genomes 18/152,274 · joint denominator
Ancestry group Frequency 1 in
South Asiangrpmax 0.193% 518
Remaining individualsnot grpmax-eligible 0.0192% 5,209
East Asian 0.00223% 44,878
European (non-Finnish) 0.00127% 78,666

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
NIPBL
Protein
p.Ser161=
Coding
c.483C>T
MANE Select
NM_133433
dbSNP
rs536895037
Type
single nucleotide variant
Location
chr5:36962147 (GRCh38)
Gene constraint
LOEUF 0.057 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Residue 161
the 'disordered' region
Full NIPBL gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nipbl-p-ser161 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown